Soligenix, Inc.
SNGX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000812796
No open-market purchases or sales by Soligenix, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $369.6K in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Soligenix, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- −2 vs. Q4 2023
- Shares held
- 239.1K
- −139.6K (−36.9%) vs. Q4 2023
- Total value
- $143.0K
- −$143.5K (−50.1%) vs. Q4 2023
- New holders
- 5
- 5 more added
- Sold out
- 7
- 2 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SNGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $369.6K |
| Q1 2026 | 15 | $307.4K |
| Q4 2025 | 19 | $600.0K |
| Q3 2025 | 23 | $1.61M |
| Q2 2025 | 15 | $248.2K |
| Q1 2025 | 11 | $313.1K |
| Q4 2024 | 10 | $82.8K |
| Q3 2024 | 7 | $262.4K |
| Q2 2024 | 11 | $259.1K |
| Q1 2024 | 18 | $143.0K |
| Q4 2023 | 20 | $286.5K |
| Q3 2023 | 19 | $500.2K |
| Q2 2023 | 20 | $1.02M |
| Q1 2023 | 16 | $195.2K |
| Q4 2022 | 36 | $1.37M |
| Q3 2022 | 30 | $1.35M |
| Q2 2022 | 28 | $1.91M |
| Q1 2022 | 33 | $2.38M |
| Q4 2021 | 28 | $2.24M |
| Q3 2021 | 34 | $4.35M |
| Q2 2021 | 34 | $4.59M |
| Q1 2021 | 35 | $5.22M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Soligenix, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| GWM Advisors LLC | 3 | $2 | 0.00% | −45−93.8% | Reduced |
| Albion Financial Group | 5 | $3 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 19 | $12 | 0.00% | 00.0% | Unchanged |
| Brown Brothers Harriman & Co | 34 | $20 | 0.00% | +34 | New |
| Advisor Group Holdings, Inc. | 53 | $32 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 81 | $49 | 0.00% | +5+6.6% | Added |
| UBS Group AG | 1,429 | $857 | 0.00% | +1,429 | New |
| Morgan Stanley | 3,594 | $2.16K | 0.00% | −7−0.2% | Reduced |
| Plante Moran Financial Advisors, LLC | 4,778 | $2.87K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 6,967 | $4.18K | 0.00% | +192+2.8% | Added |
| Two Sigma Securities, LLC | 11,435 | $6.86K | 0.00% | +11,435 | New |
| HRT Financial LP | 12,518 | $7.00K | 0.00% | +12,518 | New |
| Two Sigma Investments, LP | 12,731 | $7.64K | 0.00% | +997+8.5% | Added |
| First Wilshire Securities Management Inc | 23,334 | $14.0K | 0.00% | 00.0% | Unchanged |
| Warberg Asset Management LLC | 24,500 | $14.7K | 0.00% | +4,500+22.5% | Added |
| Nomura Holdings Inc | 30,000 | $18.0K | 0.00% | +30,000 | New |
| Vanguard Group Inc | 50,865 | $30.5K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 56,799 | $34.1K | 0.00% | +6,603+13.2% | Added |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −92,792−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −80,651−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −17,743−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Global Retirement Partners, LLC | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −211−100.0% | Sold out |
| Scarborough Advisors, LLC | 0 | $0 | 0.00% | −62−100.0% | Sold out |